Skip to content

Validation of Falls Decision Rule to Exclude Intracranial Bleeding in Geriatric Fall Patients

External Validation of the Falls Decision Rule to Exclude Intracranial Bleeding Without Head CT in Geriatric Patients Presenting to the Emergency Department With A Fall

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06525727
Enrollment
800
Registered
2024-07-29
Start date
2024-01-20
Completion date
2024-11-12
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Hemorrhages

Keywords

Falls Rule, geriatric, rule, external validation

Brief summary

Although falls are the most important cause of intracranial hemorrhage in the population over 65, studies have shown that bleeding occurs in only 5% of geriatric patients who fall. Guidelines have been developed to assist the clinician in identifying patients at risk of intracranial hemorrhage due to the relatively low incidence but significant morbidity and mortality. The 'Falls Decision Rule' was developed by de Wit et al. in 2023 to assess the need for CT in this patient group. In this study, external validation of this newly developed score was planned to evaluate its safety, applicability, and authenticity.

Detailed description

In the geriatric population (≥65 years), falls are responsible for 70% of traumatic brain injury. Computed tomography (CT) evaluation of the brain used in evaluating these patients makes it possible to detect intracranial hemorrhage in the early period. Thus, it plays a critical role in initiating timely and necessary interventions. These interventions include blood pressure control, hemorrhage control, and neurosurgical interventions. Although the most important cause of intracranial hemorrhage in this population is falls, studies have shown that bleeding occurs in only 5% of geriatric patients who fall. Therefore, it is inefficient and costly to perform brain CT evaluation in every patient. Rules have been developed to assist the clinician in identifying patients at risk of intracranial hemorrhage, which has a relatively low incidence but significant morbidity and mortality. The Canadian Brain CT rule, one of the most widely used rules for this purpose, determines the need for brain CT in patients with head trauma. However, this rule applies to patients with disorientation, amnesia, or loss of consciousness. There are insufficient studies to guide neuroimaging for older adults who hit their heads while falling but do not experience these symptoms. In addition, guidance from the literature for older adults who fall but cannot describe what happened or did not hit their heads is also insufficient. The 'Falls Decision Rule' was developed by de Wit et al. in 2023 to assess the need for CT in this patient group. This criterion was developed by including a total of 4308 patients in the United States and Canadian emergency departments. It suggests that in patients in the geriatric population, there is no need for Brain CT in the absence of significant head trauma due to falls, no memory loss due to falls, no newly developing neurological examination disorder, and a clinical frailty score of less than 5. The sensitivity of this score to exclude clinically significant bleeding is 98.6% (95% CI 94.9-99.6), and the negative predictive value is 99.8% (95% CI 99.2-99.8). This newly developed rule was developed only in a specific geographical region. In this study, external validation of this newly developed score was planned in order to evaluate its safety, applicability, and accuracy. Patients over 65 years of age who come to the emergency department with a fall will be observationally recorded on the case form after obtaining consent from the patient or his/her relatives and will be followed up for clinically significant intracranial hemorrhage within 42 days. This study is a validation study, and the protocol used in the original study will be followed. The study is a prospective observational study. The study will start after ethics committee approval and will be conducted at Marmara University Pendik Training and Research Hospital. The data collection process will be completed when the targeted sample size is reached. The sample size was calculated for the diagnostic value study planned to validate the fall decision rule developed by de Wit et al. to rule out patients with intracranial hemorrhage. Using the incidence, sensitivity, and specificity values shared by the authors as a reference, the minimum sample size to be included in the study was calculated as 663, with 80% power and 0.05% margin of error. Considering the risk of missing and inaccurate measurements, the target sample size was increased by 15% and set as 763. Data will be obtained from patient files, Hospital Information Management System, and PACS systems; Demographic information (age, gender), Known diseases (HT, DM, AF, CHF, etc.), Information on falls, Physical examination information), Consultation notes, if any, Antiplatelet, anticoagulant use, Frailty score, The CT scan results will be saved. Patients will be followed up for delayed intracranial hemorrhage within 42 days after the fall as in the original study. Also as in the methodology of the original study, patients will be followed up through the electronic information system. Previous studies have shown that this method has a low sensitivity (37%, 95% CI 21-56) for intracranial hemorrhage when patients are questioned for intracranial hemorrhage by telephone call. Therefore, in the original study and this study, it was planned to follow up the information of the patients from the electronic information system records instead of telephoning. The intracranial hemorrhage status of the patients within 42 days will be followed up through the hospital information system and patient information system.

Interventions

OTHERFalls Decision Rule

The Falls Decision Rule is a rule used to assess the risk of intracranial haemorrhage in geriatric patients and to prevent brain tomography (CT) in low-risk patients. This rule recommends that brain CT is not necessary in patients who do not have significant head trauma, memory loss, newly developing neurological examination disorder, or frailty score lower than 5 after a fall.

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 65 years and older. * Patients who presented to the emergency department within 48 hours of a fall. * Patients who provided informed consent to participate in the study or whose legal guardians provided consent if the patients are unable to do so.

Exclusion criteria

* Patients who have already been included in the study previously. * Patients who refuse medical treatment or withdraw consent during the study period. * Patients with incomplete data necessary for the study.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With the Clinically Important Intracranial BleedingFrom baseline to 42 days (Patients will be followed up for 42 days after the fall and evaluated for delayed intracranial haemorrhage).The primary outcome is 'clinically significant intracranial hemorrhage' identified within 42 days following the initial presentation in the emergency department. 'Clinically significant intracranial hemorrhage' is defined as hemorrhage within the cranial vault, encompassing subdural, intracerebral, intraventricular, subarachnoid, epidural hemorrhage, and cerebral contusion, necessitating medical or surgical intervention. Medical intervention is defined as any of the following actions: temporary or permanent cessation of anticoagulant or antiplatelet medications; administration of an antifibrinolytic agent; reversal of anticoagulation; or hospitalization for neurological monitoring. These criteria align with those established in the original study.

Secondary

MeasureTime frameDescription
Number of Participant With Neurosurgical Intervention42 dayNeurosurgical intervention was defined as any surgical procedure performed to manage clinically important intracranial bleeding (CIIB) identified either at the initial emergency department visit or during the 42-day follow-up period.
Number of Patients With Mortality42 dayMortality was defined as death occurring at any point during the 42-day follow-up period, regardless of whether it was directly attributed to clinically important intracranial bleeding (CIIB). Deaths were identified through national healthcare system.

Countries

Turkey (Türkiye)

Participant flow

Recruitment details

The study recruited patients aged 65 years and older who presented to the emergency department of Marmara University Pendik Training and Research Hospital within 48 hours of a fall on level ground, from a chair, toilet seat, or out of bed. Recruitment began on January 20, 2024, and continued until the required sample size was reached on October 1, 2024, ensuring adequate participant inclusion.

Participants by arm

ArmCount
Patients Identified With CIIB on Initial Visit and 42 Day Follow-up
This group includes patients aged 65 years and older who were diagnosed with clinically important intracranial bleeding (CIIB) either at the initial emergency department visit or during the 42-day follow-up period. CIIB was defined as intracranial bleeding requiring medical or surgical intervention or resulting in mortality. Patients in this group were managed according to clinical guidelines, and those not initially identified with CIIB were closely monitored for delayed bleeding.
49
Patients Without CIIB
This group includes patients aged 65 years and older who were not diagnosed with clinically important intracranial bleeding (CIIB) during the initial emergency department visit or the 42-day follow-up period. These patients either did not undergo head CT or had a negative CT result at presentation, with no subsequent evidence of intracranial bleeding requiring medical or surgical intervention. Additionally, they exhibited no signs of bleeding throughout the follow-up period and did not experience fatal outcomes related to CIIB.
751
Total800

Baseline characteristics

CharacteristicPatients Identified With CIIB on Initial Visit and 42 Day Follow-upTotalPatients Without CIIB
Abnormal neurological examination from baseline19 Participants36 Participants17 Participants
Age, Continuous80.0 years78.0 years78.0 years
Clinical Frailty Scale score
1 Healthy, active and very fit
3 Participants88 Participants85 Participants
Clinical Frailty Scale score
2 No disease symptoms, occasional exercise
9 Participants179 Participants170 Participants
Clinical Frailty Scale score
3 Controlled medical issues, walk only
11 Participants221 Participants210 Participants
Clinical Frailty Scale score
4 Symptoms limit activities
5 Participants118 Participants113 Participants
Clinical Frailty Scale score
5 Need help with daily living activities^
2 Participants71 Participants69 Participants
Clinical Frailty Scale score
6 Need help with bathing/dressing
9 Participants62 Participants53 Participants
Clinical Frailty Scale score
7-8 Completely dependent for everything
9 Participants53 Participants44 Participants
Clinical Frailty Scale score
9 Terminally ill, life expectancy < 6 months
1 Participants8 Participants7 Participants
Confirmed history of amnesia of events20 Participants89 Participants69 Participants
Confirmed history of head trauma41 Participants448 Participants407 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Turkey
49 participants800 participants751 participants
Sex: Female, Male
Female
22 Participants479 Participants457 Participants
Sex: Female, Male
Male
27 Participants321 Participants294 Participants
Unclear history of amnesia of events12 Participants39 Participants27 Participants
Unclear history of head trauma3 Participants39 Participants36 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
12 / 4934 / 751
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Number of Participants With the Clinically Important Intracranial Bleeding

The primary outcome is 'clinically significant intracranial hemorrhage' identified within 42 days following the initial presentation in the emergency department. 'Clinically significant intracranial hemorrhage' is defined as hemorrhage within the cranial vault, encompassing subdural, intracerebral, intraventricular, subarachnoid, epidural hemorrhage, and cerebral contusion, necessitating medical or surgical intervention. Medical intervention is defined as any of the following actions: temporary or permanent cessation of anticoagulant or antiplatelet medications; administration of an antifibrinolytic agent; reversal of anticoagulation; or hospitalization for neurological monitoring. These criteria align with those established in the original study.

Time frame: From baseline to 42 days (Patients will be followed up for 42 days after the fall and evaluated for delayed intracranial haemorrhage).

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Patients Need Head CT According to Falls Decision RuleNumber of Participants With the Clinically Important Intracranial Bleeding48 Participants
Patients do Not Need Head CT According to Falls Decision RuleNumber of Participants With the Clinically Important Intracranial Bleeding1 Participants
Comparison: The primary objective of the study was to assess the external validation of the Falls Decision Rule. In this evaluation, patients were categorized into two groups based on the rule: those for whom a CT scan was recommended and those for whom it was not.95% CI: [89.15, 99.95]Diagnostic accuracy
95% CI: [28.63, 35.42]Diagnostic accuracy
95% CI: [97.17, 99.94]Diagnostic accuracy
95% CI: [8.1, 9.1]Diagnostic accuracy
95% CI: [0.01, 0.42]Diagnostic accuracy
95% CI: [1.35, 1.53]Diagnostic accuracy
Secondary

Number of Participant With Neurosurgical Intervention

Neurosurgical intervention was defined as any surgical procedure performed to manage clinically important intracranial bleeding (CIIB) identified either at the initial emergency department visit or during the 42-day follow-up period.

Time frame: 42 day

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Patients Need Head CT According to Falls Decision RuleNumber of Participant With Neurosurgical Intervention6 Participants
Patients do Not Need Head CT According to Falls Decision RuleNumber of Participant With Neurosurgical Intervention0 Participants
Secondary

Number of Patients With Mortality

Mortality was defined as death occurring at any point during the 42-day follow-up period, regardless of whether it was directly attributed to clinically important intracranial bleeding (CIIB). Deaths were identified through national healthcare system.

Time frame: 42 day

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Patients Need Head CT According to Falls Decision RuleNumber of Patients With Mortality12 Participants
Patients do Not Need Head CT According to Falls Decision RuleNumber of Patients With Mortality34 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026